Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To estimate the antitumor activity of the combination of gemcitabine and cisplatin in
patients with advanced (stage III or IV) or recurrent endometrial cancer.
Secondary Objective:
- To determine the nature and degree of toxicity of the combination of gemcitabine and
cisplatin in this cohort of patients.